Microarray analysis have detected an upregulation of FOXM1 in human retinoblastoma [31], and in retinoblastoma Y79 cells, FOXM1 depletion has been shown to affect cell invasive capacity by targeting MMP2 [32]. The gene discussed is MMP2; the disease is retinoblastoma.